{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:39:58Z","timestamp":1790959198694,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["45\/7\/2020-\/DDI\/BMS"],"award-info":[{"award-number":["45\/7\/2020-\/DDI\/BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.lfs.2024.122680","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T15:54:48Z","timestamp":1714492488000},"page":"122680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["H-ras-targeted genetic therapy remarkably surpassed docetaxel treatment in inhibiting chemically induced hepatic tumors in rats"],"prefix":"10.1016","volume":"348","author":[{"given":"Alankar","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramkrishna","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashique","family":"Al Hoque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tapan Kumar","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswajit","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2024.122680_bb0005","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2024.122680_bb0010","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.lfs.2024.122680_bb0015","author":"WHO"},{"key":"10.1016\/j.lfs.2024.122680_bb0020","series-title":"Nanotherapeutics for the Treatment of Hepatocellular Carcinoma","first-page":"1","article-title":"Hepatocellular carcinoma: diagnosis, molecular pathogenesis, biomarkers, and conventional therapy","author":"Mukherjee","year":"2022"},{"key":"10.1016\/j.lfs.2024.122680_bb0025","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052608","article-title":"Clinical potential of kinase inhibitors in combination with immune checkpoint inhibitors for the treatment of solid tumors","volume":"22","author":"Ahn","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.122680_bb0030","series-title":"Novel Molecular Oncotargets and Nano-oncotherapeutics","first-page":"495","article-title":"(2023) targeted nanotherapeutics: promising therapeutic arsenal against hepatocellular carcinoma","author":"Mukherjee","year":"2023"},{"key":"10.1016\/j.lfs.2024.122680_bb0035","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/practneurol-2017-001764","article-title":"Antisense oligonucleotides and other genetic therapies made simple","volume":"18","author":"Rossor","year":"2018","journal-title":"Pract. Neurol."},{"key":"10.1016\/j.lfs.2024.122680_bb0040","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1080\/17425255.2021.1992382","article-title":"Antisense oligonucleotides: absorption, distribution, metabolism, and excretion","volume":"17","author":"Shadid","year":"2021","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.lfs.2024.122680_bb0045","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.lfs.2024.122680_bb0050","doi-asserted-by":"crossref","DOI":"10.1186\/1477-3163-4-12","article-title":"Characterization of insulin-like-growth factor II (IGF II) mRNA positive hepatic altered foci and IGF II expression in hepatocellular carcinoma during diethylnitrosamine-induced hepatocarcinogenesis in rats","volume":"4","author":"Mukherjee","year":"2005","journal-title":"J Carcinog."},{"key":"10.1016\/j.lfs.2024.122680_bb0055","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ymthe.2020.12.022","article-title":"Clinical applications of single-stranded oligonucleotides: current landscape of approved and in-development therapeutics","volume":"29","author":"Scharner","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.lfs.2024.122680_bb0060","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41388-021-02130-8","article-title":"Elevated expression of RIT1 hyperactivates RAS\/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor","volume":"41","author":"Sun","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2024.122680_bb0065","first-page":"4951","article-title":"PI-103 and sorafenib inhibit hepatocellular carcinoma cell proliferation by blocking Ras\/Raf\/MAPK and PI3K\/AKT\/mTOR pathways","volume":"30","author":"Gedaly","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/j.lfs.2024.122680_bb0070","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3892\/ol.2017.5557","article-title":"Targeting the Ras\/Raf\/MEK\/ERK pathway in hepatocellular carcinoma","volume":"13","author":"Yang","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2024.122680_bb0075","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3892\/ol.2012.832","article-title":"Study of the correlation between H-ras mutation and primary hepatocellular carcinoma","volume":"4","author":"Sui","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.lfs.2024.122680_bb0080","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1073\/pnas.96.12.7065","article-title":"Guanosine triphosphatase stimulation of oncogenic Ras mutants","volume":"96","author":"Ahmadian","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2024.122680_bb0085","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1177\/0300985810388526","article-title":"H-ras consensus sequence and mutations in primary hepatocellular carcinomas of lemurs and lorises","volume":"48","author":"Cullen","year":"2011","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.lfs.2024.122680_bb0090","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijms.2010.06.001","article-title":"Detecting low-level synthesis impurities in modified phosphorothioate oligonucleotides using liquid chromatography-high resolution mass spectrometry","volume":"304","author":"Nikcevic","year":"2011","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.lfs.2024.122680_bb0095","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/ac960916h","article-title":"Analysis of oligonucleotides by HPLC-electrospray ionization mass spectrometry","volume":"69","author":"Apffel","year":"1997","journal-title":"Anal. Chem."},{"key":"10.1016\/j.lfs.2024.122680_bb0100","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1080\/10717544.2016.1253798","article-title":"Successful delivery of docetaxel to rat brain using experimentally developed nanoliposome: a treatment strategy for brain tumor","volume":"24","author":"Shaw","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.lfs.2024.122680_bb0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/1061186X.2023.2199350","article-title":"Cetuximab-conjugated PLGA nanoparticles as a prospective targeting therapeutics for non-small cell lung cancer","volume":"31","author":"Kumari","year":"2023","journal-title":"J. Drug Target."},{"key":"10.1016\/j.lfs.2024.122680_bb0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ultramic.2003.08.025","article-title":"TRICE-A program for reconstructing 3D reciprocal space and determining unit-cell parameters","volume":"98","author":"Zou","year":"2004","journal-title":"Ultramicroscopy"},{"key":"10.1016\/j.lfs.2024.122680_bb0115","article-title":"Antisense oligonucleotides directed against insulin-like growth factor-II messenger ribonucleic acids delay the progress of rat hepatocarcinogenesis","volume":"13","author":"Ghosh","year":"2014","journal-title":"J. Carcinog."},{"key":"10.1016\/j.lfs.2024.122680_bb0120","first-page":"455","article-title":"Biochemical basis of selenomethionine-mediated inhibition during 2-acetylaminofluorene-induced hepatocarcinogenesis in the rat","volume":"5","author":"Mukherjee","year":"1996","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.lfs.2024.122680_bb0125","first-page":"186","article-title":"Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma","volume":"24","author":"Hanif","year":"2014","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.lfs.2024.122680_bb0130","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1097\/00000478-200006000-00014","article-title":"Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis","volume":"24","author":"Rullier","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.lfs.2024.122680_bb0135","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.prp.2010.03.004","article-title":"The best immunohistochemical panel for differentiating hepatocellular carcinoma from metastatic adenocarcinoma","volume":"206","author":"Karabork","year":"2010","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.lfs.2024.122680_bb0140","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1002\/1097-0142(19930615)71:12<3864::AID-CNCR2820711212>3.0.CO;2-5","article-title":"Expression of the CD15 antigen in hepatocellular carcinoma","volume":"71","author":"Torii","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2024.122680_bb0145","article-title":"p53 immunohistochemistry patterns are surrogate biomarkers for TP53 mutations in gastrointestinal neuroendocrine neoplasms","volume":"15","author":"Li","year":"2021","journal-title":"Gastroenterol Res Pract."},{"key":"10.1016\/j.lfs.2024.122680_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abo1827","article-title":"Structural and biochemical characteristics of mRNA nanoparticles determine anti\u2013SARS-CoV-2 humoral and cellular immune responses","volume":"8","author":"Shi","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.lfs.2024.122680_bb0155","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/1091581819831701","article-title":"Kidney pathophysiology, toxicology, and drug-induced injury in drug development","volume":"38","author":"Radi","year":"2019","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.lfs.2024.122680_bb0160","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/1097-0142(20010901)92:5<1265::AID-CNCR1447>3.0.CO;2-5","article-title":"A phase I trial of H-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma","volume":"92","author":"Cunningham","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.lfs.2024.122680_bb0165","series-title":"Statistics in Pharmacokinetics in Pharmacokinetics: Basics to Applications","first-page":"199","author":"Mukherjee","year":"2022"},{"key":"10.1016\/j.lfs.2024.122680_bb0170","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/s41374-018-0057-0","article-title":"Principles and approaches for reproducible scoring of tissue stains in research","volume":"98","author":"Meyerholz","year":"2018","journal-title":"Lab. Invest."},{"key":"10.1016\/j.lfs.2024.122680_bb0175","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-014-0221-9","article-title":"Different approaches for interpretation and reporting of immunohistochemistry analysis results in the bone tissue \u2013 a review","volume":"9","author":"Fedchenko","year":"2014","journal-title":"Diagn Pathol."},{"key":"10.1016\/j.lfs.2024.122680_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/1746-1596-7-42","article-title":"Quantitative comparison of immuno-histochemical staining measured by digital image analysis versus pathologist visual scoring","volume":"7","author":"Rizzardi","year":"2012","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.lfs.2024.122680_bb0185","first-page":"2004","article-title":"Scanning and transmission electron microscopy study of a human breast carcinoma cell line (MCF-7) cultured in collagen-coated cellulose sponge","volume":"37","author":"Russo","year":"1977","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2024.122680_bb0190","first-page":"1541","article-title":"In vivo differentiation of rat liver oval cells into hepatocytes","volume":"49","author":"Evarts","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2024.122680_bb0195","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2121-14-32","article-title":"Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis","volume":"14","author":"Brentnall","year":"2013","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.lfs.2024.122680_bb0200","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/nar\/gkx1239","article-title":"Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs","volume":"46","author":"Shen","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2024.122680_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/1735-5362.278710","article-title":"Development of a RP-HPLC method for analysis of docetaxel in tumor-bearing mice plasma and tissues following injection of docetaxel-loaded pH responsive targeting polymeric micelles","volume":"15","author":"Kazemi","year":"2020","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.lfs.2024.122680_bb0210","article-title":"Antisense oligonucleotides: treatment strategies and cellular internalization","volume":"3","author":"Miller","year":"2016","journal-title":"RNA Dis."},{"key":"10.1016\/j.lfs.2024.122680_bb0215","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2020","key":"10.1016\/j.lfs.2024.122680_bb0220","first-page":"1","article-title":"Antisense oligonucleotides: an emerging area in drug discovery and development","volume":"9","author":"Dhuri","year":"2004","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2024.122680_bb0225","series-title":"StatPearls [Internet]","article-title":"Drug elimination (2023 Jul 4.)","author":"Garza","year":"2024"},{"key":"10.1016\/j.lfs.2024.122680_bb0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/bja\/aeg117","article-title":"Drug handling by the lungs","volume":"91","author":"Boer","year":"2003","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.lfs.2024.122680_bb0235","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1093\/nar\/gkw112","article-title":"Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver","volume":"44","author":"Miller","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2024.122680_bb0240","first-page":"7314","article-title":"Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides","volume":"44","author":"Wang","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2024.122680_bb0245","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/nat.2017.0694","article-title":"Endosomal escape of antisense oligonucleotides internalized by stabilin receptors is regulated by Rab5C and EEA1 during endosomal maturation","volume":"28","author":"Miller","year":"2018","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.lfs.2024.122680_bb0250","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1093\/nar\/gkx231","article-title":"Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2024.122680_bb0255","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","article-title":"Therapeutic antisense oligonucleotides are coming of age","volume":"70","author":"Bennett","year":"2019","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.lfs.2024.122680_bb0260","doi-asserted-by":"crossref","first-page":"S361","DOI":"10.1016\/S1590-8658(11)60592-6","article-title":"Liver precancerous lesions and hepatocellular carcinoma: the histology report","volume":"43","author":"Roncalli","year":"2011","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.lfs.2024.122680_bb0265","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.hpb.2017.06.002","article-title":"A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy","volume":"19","author":"Yang","year":"2017","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.lfs.2024.122680_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14092203","article-title":"Prognostic and therapeutic role of CD15 and CD15s in cancer","volume":"14","author":"Szlasa","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.lfs.2024.122680_bb0275","doi-asserted-by":"crossref","first-page":"95","DOI":"10.20517\/2394-5079.2017.07","article-title":"Roles of p53 in extrinsic factor-induced liver carcinogenesis","volume":"3","author":"Link","year":"2017","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.lfs.2024.122680_bb0280","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semcancer.2010.09.001","article-title":"Intracellular signaling and hepato cellular carcinoma","volume":"21","author":"Iakova","year":"2011","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.lfs.2024.122680_bb0285","doi-asserted-by":"crossref","first-page":"114","DOI":"10.20517\/2394-5079.2015.67","article-title":"Murine double minute 2, a potential p53-independent regulator of liver cancer metastasis","volume":"2","author":"Ranjan","year":"2016","journal-title":"Hepatoma Res."},{"key":"10.1016\/j.lfs.2024.122680_bb0290","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.biopha.2016.10.051","article-title":"MicroRNA-24 increases hepatocellular carcinoma cell metastasis and invasion by targeting p53: miR-24 targeted p53","volume":"84","author":"Chen","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2024.122680_bb0295","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1083\/jcb.201903090","article-title":"The cell biology of the hepatocyte: a membrane trafficking machine","volume":"218","author":"Schulze","year":"2019","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.lfs.2024.122680_bb0300","first-page":"187","article-title":"Relationship between development of microvilli on tumor cells and growth or metastatic potential of tumor cells","volume":"66","author":"Ren","year":"1991","journal-title":"Hokkaido Igaku Zasshi"},{"key":"10.1016\/j.lfs.2024.122680_bb0305","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1021\/acs.molpharmaceut.0c00977","article-title":"Apigenin-loaded PLGA-DMSA nanoparticles: a novel strategy to treat melanoma lung metastasis","volume":"18","author":"Sen","year":"2021","journal-title":"Mol. Pharm."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524002704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524002704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T11:51:28Z","timestamp":1716119488000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524002704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":61,"alternative-id":["S0024320524002704"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122680","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H-ras-targeted genetic therapy remarkably surpassed docetaxel treatment in inhibiting chemically induced hepatic tumors in rats","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.122680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122680"}}